Inside the research

Integer Holdings Corporation

ITGR Research profile · latest available data

Price overview

$126.34

▲ +0.17 (+0.1%)

52w hi$126.50
52w lo$63.32
Vol567.40K
As of25 Sep 2026

The Verdict

Hold

Our score +0.25

Short+0.36
Medium+0.34
Long-0.14

computed 2026-09-27

Key fundamentals

Integer Holdings Corporation

Healthcare · Medical Devices

Market cap$4.30B
Enterprise value$5.64B
Trailing P/E34.61x
Forward P/E18.39x
EV / EBITDA16.21x
P / S (ttm)2.33x
Profit margin7.0%
Return on equity7.5%
Revenue growth-2.6%
Earnings growth-33.7%
Debt / equity79.39

Layer Breakdown

LayerRawContribution
Fundamental+0.04
Sector+0.08
Technical+0.25
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

United States · www.integer.net

Risk Metrics

Beta vs SPX0.80
Corr SPX0.34
Annual vol38.3%
Annual ret+6.8%
Sharpe0.18
Max DD-56.1%

Window: 504 trading days (504 obs)

Material Events

DateEvent8-K
2026-08-04Material Agreement, Bylaws Amendment…read
2026-08-03Reg FD Disclosure, Exhibitsread
2026-08-03Earnings Release, Exhibitsread
2026-06-26Officer / Director Changeread
2026-05-22Officer / Director Change, Shareholder Vote…read
2026-04-30Earnings Release, Reg FD Disclosure…read
2026-03-12Material Agreement, Officer / Director Change…read
2026-02-19Earnings Release, Reg FD Disclosure…read
2025-11-04Other Material Event, Exhibitsread
2025-10-24Officer / Director Change, Reg FD Disclosure…read
2025-10-23Earnings Release, Reg FD Disclosure…read
2025-07-24Earnings Release, Reg FD Disclosure…read

Insider Trades

DateInsiderRoleActionSharesValue
2026-06-30Thor Kirk KChief Human Resources OffOption exercise6.12K—
2026-06-30Thor Kirk KChief Human Resources OffWithheld for tax2.41K$225.12K
2026-05-20MAXWELL MARTIN CGrant1.97K—
2026-05-20COYLE MICHAEL JGrant1.97K—
2026-05-20Kapito AaronGrant1.97K—
2026-05-20Jeffers Alvin TyroneGrant1.97K—
2026-05-20Capps Cheryl CGrant1.97K—
2026-05-20Antrum SheilaGrant1.97K—

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders7
Top-5 share100.0%
HHI4,964 (concentrated)

Top Holders

HolderValueShares
Citadel Advisors$91.49M979.05K
State Street Corp$25.47M26.32M
Fidelity / FMR LLC$10.97M11.35M
AQR Capital Management$7.26M77.69K
Millennium Management$845.91K875.00K
Capital Research / Capital World$38.96K32.00K
T. Rowe Price Group$4.00K42.77K

As of 2026-06-30

SEC Filings

DateFormDoc
2026-08-04DEFA14Aview
2026-08-048-Kview
2026-08-0410-Qview
2026-08-03DEFA14Aview
2026-08-038-Kview
2026-08-03DEFA14Aview
2026-08-03DEFA14Aview
2026-08-03DEFA14Aview
2026-08-03DEFA14Aview
2026-08-03DEFA14Aview
2026-08-03DEFA14Aview
2026-08-038-Kview
2026-08-03DEFA14Aview
2026-07-104view
2026-07-103view

The Long Run

FY 2011–2025 · 15 years

LineLatestCAGRTrend
Revenue$1.56B+8.1%
Gross profit$500.39M+7.6%
Operating income$221.26M+46.6%
Net income$102.81M+9.1%
Cash from ops$196.15M+5.7%

Indices

S&P SmallCap 600

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$126.26$126.35$126.21$126.34567.40K
Sep 24$126.30$126.43$126.16$126.17816.60K
Sep 23$126.40$126.44$126.28$126.32527.90K
Sep 22$126.40$126.44$126.32$126.33555.00K
Sep 21$126.53$126.53$126.27$126.38685.60K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →